{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:46:27Z","timestamp":1791013587916,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1986,12,1]],"date-time":"1986-12-01T00:00:00Z","timestamp":533779200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Toxicology"],"published-print":{"date-parts":[[1986,12]]},"DOI":"10.1007\/bf03259853","type":"journal-article","created":{"date-parts":[[2016,2,7]],"date-time":"2016-02-07T20:31:54Z","timestamp":1454877114000},"page":"421-427","source":"Crossref","is-referenced-by-count":202,"title":["Vincristine Neurotoxicity"],"prefix":"10.1007","volume":"1","author":[{"given":"Sewa S.","family":"Legha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,27]]},"reference":[{"key":"BF03259853_CR1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0140-6736(71)92227-6","volume":"1","author":"A Agosti","year":"1971","unstructured":"Agosti A, Bertaccini G, Paulucci R, Zanella E. Caerulein treatment for paralytic ileus. Lancet 1: 395, 1971","journal-title":"Lancet"},{"key":"BF03259853_CR2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00005072-196701000-00002","volume":"26","author":"PJ Anderson","year":"1967","unstructured":"Anderson PJ, Song SK, Slotwiner P. Fine structure of sphenomembranous degeneration of skeletal muscle induced by vincristine. Journal of Neuropathology and Experimental Neurology 26: 15\u201324, 1967","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"BF03259853_CR3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-93-5-781_2","volume":"93","author":"AW Awida","year":"1980","unstructured":"Awida AW. Blindness and vincristine. Annals of Internal Medicine 93: 781, 1980","journal-title":"Annals of Internal Medicine"},{"key":"BF03259853_CR4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0022-510X(70)90014-6","volume":"10","author":"WG Bradley","year":"1970","unstructured":"Bradley WG. Neuropathy of vincristine in the guinea pig: an electrophysiological and pathological study. Journal of Neurological Science 10: 133\u2013162, 1970","journal-title":"Journal of Neurological Science"},{"key":"BF03259853_CR5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0022-510X(70)90013-4","volume":"10","author":"WB Bradley","year":"1970","unstructured":"Bradley WB, Lassman LP, Pearce GW, et al. Neuropathy of vincristine in man. Journal of Neurological Science 10: 107\u2013131, 1970","journal-title":"Journal of Neurological Science"},{"key":"BF03259853_CR6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/jnci\/37.3.331","volume":"37","author":"JA Burdman","year":"1966","unstructured":"Burdman JA. Note of the selective toxicity of vincristine sulfate on chick-embryo sensory ganglia in tissue culture. Journal of the National Cancer Institute 37: 331\u2013332, 1966","journal-title":"Journal of the National Cancer Institute"},{"key":"BF03259853_CR7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/brain\/96.1.69","volume":"96","author":"EB Casey","year":"1973","unstructured":"Casey EB, Jellife AM, LeQuesne PM, Millett YL. Vincristine neuropathy: clinical and electrophysiological observations. Brain 96: 69\u201386, 1973","journal-title":"Brain"},{"key":"BF03259853_CR8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00005072-197204000-00003","volume":"31","author":"JT Clark","year":"1972","unstructured":"Clark JT, Karpati G, Carpenter S, et al. Effect of vincristine on skeletal muscle in the rat. Journal of Neuropathology and Experimental Neurology 31: 247\u2013256, 1972","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"BF03259853_CR9","first-page":"359","volume":"64","author":"NJ DiBella","year":"1980","unstructured":"DiBella NJ. Vincristine-induced orthostatic hypotension: a prospective study. Cancer Treatment Reports 64: 359\u2013360, 1980","journal-title":"Cancer Treatment Reports"},{"key":"BF03259853_CR10","first-page":"1309","volume":"69","author":"HS Garewal","year":"1985","unstructured":"Garewal HS, Dalton WS. Metoclopramide in vincristine-induced ileus. Cancer Treatment Reports 69: 1309\u20131311, 1985","journal-title":"Cancer Treatment Reports"},{"key":"BF03259853_CR11","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1212\/WNL.18.9.875","volume":"18","author":"PG Gottschalk","year":"1968","unstructured":"Gottschalk PG, Dyck PJ, Kiely JM. Vinca alkaloid neuropathy: nerve biopsy studies in rats and in man. Neurology 18: 875\u2013882, 1968","journal-title":"Neurology"},{"key":"BF03259853_CR12","first-page":"57","volume":"45","author":"R Grinberg","year":"1969","unstructured":"Grinberg R, Nemoto T, Dao TL. Vincristine (NSC-67574): dosage and response in advanced breast cancer. Cancer Chemotherapy Reports 45: 57\u201361, 1969","journal-title":"Cancer Chemotherapy Reports"},{"key":"BF03259853_CR13","doi-asserted-by":"crossref","unstructured":"Hancock BW, Naysmith A. Vincristine-induced autonomic neuropathy. British Medical Journal 207: July 26, 1975","DOI":"10.1136\/bmj.3.5977.207"},{"key":"BF03259853_CR14","first-page":"486","volume":"71","author":"J Hildebrand","year":"1971","unstructured":"Hildebrand J, Kenis Y. Additive toxicity of vincristine and other drugs for the peripheral nervous system. Acta Neurology Belgium 71: 486\u2013491, 1971","journal-title":"Acta Neurology Belgium"},{"key":"BF03259853_CR15","first-page":"1258","volume":"33","author":"JF Holland","year":"1973","unstructured":"Holland JF, Scharlau C, Gailani S, Krant MJ, Olson KB, et al. Vincristine treatment of advanced cancer: a cooperative study of 392 cases. Cancer Research 33: 1258\u20131264, 1973","journal-title":"Cancer Research"},{"key":"BF03259853_CR16","first-page":"887","volume":"23","author":"D Jackson","year":"1982","unstructured":"Jackson D, Rosenbaum D, Carlisle L, Wells B, Long T, et al. Glutamic acid modification of vincristine-induced toxicity. Proceedings of the American Association of Cancer Research 23: 887, 1982","journal-title":"Proceedings of the American Association of Cancer Research"},{"key":"BF03259853_CR17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0022-3476(73)80602-X","volume":"82","author":"FL Johnson","year":"1973","unstructured":"Johnson FL, Bernstein ID, Hartmann JR, et al. Seizures associated with vincristine sulfate therapy. Journal of Pediatrics 82: 699\u2013702, 1973","journal-title":"Journal of Pediatrics"},{"key":"BF03259853_CR18","first-page":"69","volume":"39","author":"LJ Journey","year":"1968","unstructured":"Journey LJ, Burdman J, Whaley A. Ultrastructural studies on the in vivo effects of vincristine sulfate on mouse spinal ganglia. (Abstract 166). Journal of Cell Biology 39: 69a, 1968","journal-title":"(Abstract 166). Journal of Cell Biology"},{"key":"BF03259853_CR19","first-page":"103","volume":"9","author":"RS Kaplan","year":"1982","unstructured":"Kaplan RS, Wiernik PH. Neurotoxicity of antineoplastic drugs. Seminars in Oncology 9: 103\u2013130, 1982","journal-title":"Seminars in Oncology"},{"key":"BF03259853_CR20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0022-3476(76)80416-7","volume":"89","author":"IA Kaufman","year":"1976","unstructured":"Kaufman IA, Kung FH, Koenig HM, Giammona ST. Overdosage with vincristine. Journal of Pediatrics 89: 671\u2013674, 1976","journal-title":"Journal of Pediatrics"},{"key":"BF03259853_CR21","first-page":"249","volume":"53","author":"BC Korbitz","year":"1969","unstructured":"Korbitz BC, Davis HL Jr, Ramirez G, Ansfield FJ. Low doses of vincristine (NSC-67574) for malignant disease. Cancer Chemotherapy Reports 53: 249\u2013254, 1969","journal-title":"Cancer Chemotherapy Reports"},{"key":"BF03259853_CR22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/jnnp.32.4.297","volume":"32","author":"JG McLeod","year":"1969","unstructured":"McLeod JG, Penny R. Vincristine neuropathy: an electrophysiological and histological study. Journal of Neurology, Neuro-surgery and Psychiatry 32: 297\u2013304, 1969","journal-title":"Journal of Neurology, Neuro-surgery and Psychiatry"},{"key":"BF03259853_CR23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/archneur.1967.00470220041005","volume":"16","author":"GR Moress","year":"1967","unstructured":"Moress GR, D\u2019Agostino AW, Jarcho LW. Neuropathy in lymphoblastic leukemia treated with vincristine. Archives of Neurology 16: 377\u2013384, 1967","journal-title":"Archives of Neurology"},{"key":"BF03259853_CR24","first-page":"221","volume-title":"The anticancer drugs","author":"WB Pratt","year":"1974","unstructured":"Pratt WB, Ruddon RW. The anticancer drugs, pp. 221\u2013233, Oxford University Press, New York, 1974"},{"key":"BF03259853_CR25","doi-asserted-by":"crossref","first-page":"733","DOI":"10.7326\/0003-4819-80-6-733","volume":"80","author":"S Rosenthal","year":"1974","unstructured":"Rosenthal S, Kaufman S. Vincristine neurotoxicity. Annals of Internal Medicine 80: 733\u2013737, 1974","journal-title":"Annals of Internal Medicine"},{"key":"BF03259853_CR26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/1097-0142(19830201)51:3<423::AID-CNCR2820510311>3.0.CO;2-3","volume":"51","author":"JR Ryan","year":"1983","unstructured":"Ryan JR, Emami A. Vincristine neurotoxicity with residual equinocavus deformity in children with acute leukemia. Cancer 51: 423\u2013425, 1983","journal-title":"Cancer"},{"key":"BF03259853_CR27","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1212\/WNL.19.4.367","volume":"19","author":"SG Sandler","year":"1969","unstructured":"Sandler SG, Tobin W, Henderson ES. Vincristine-induced neuropathy. Neurology 19: 367\u2013374, 1969","journal-title":"Neurology"},{"key":"BF03259853_CR28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF00179439","volume":"3","author":"W Scheithauer","year":"1985","unstructured":"Scheithauer W, Ludwig H, Maida E. Acute encephalopathy associated with continuous vincristine sulfate combination therapy: case report. Investigational New Drugs 3: 315\u2013318, 1985","journal-title":"Investigational New Drugs"},{"key":"BF03259853_CR29","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/00005072-197107000-00012","volume":"30","author":"WN Schlaepfer","year":"1971","unstructured":"Schlaepfer WN. Vincristine-induced axonal alterations in rat peripheral nerve. Journal of Neuropathology and Experimental Neurology 30: 488\u2013505, 1971","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"BF03259853_CR30","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00005072-196810000-00008","volume":"27","author":"SS Schochet","year":"1968","unstructured":"Schochet SS, Lampert PW, Earle KM. Neuronal changes induced by intrathecal vincristine sulfate. Journal of Neuropathology and Experimental Neurology 27: 645\u2013658, 1968","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"BF03259853_CR31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archneur.1969.00480080099012","volume":"20","author":"ML Shelanski","year":"1969","unstructured":"Shelanski ML, Wisniewski H. Neurofibrillary degeneration: induced by vincristine therapy. Archives of Neurology 20: 199\u2013206, 1969","journal-title":"Archives of Neurology"},{"key":"BF03259853_CR32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/mpo.2950050113","volume":"5","author":"DA Shepherd","year":"1978","unstructured":"Shepherd DA, Steuber CP, Starling KA, Fernbach DJ. Accidental intrathecal administration of vincristine. Medical Pediatric Oncology 5: 85\u201388, 1978","journal-title":"Medical Pediatric Oncology"},{"key":"BF03259853_CR33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/1097-0142(196901)23:1<122::AID-CNCR2820230114>3.0.CO;2-E","volume":"23","author":"LM Slater","year":"1969","unstructured":"Slater LM, Weiner RA, Serpick AA. Vincristine neurotoxicity with hyponatremia. Cancer 23: 122\u2013125, 1969","journal-title":"Cancer"},{"key":"BF03259853_CR34","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/archneur.1966.00470140062008","volume":"15","author":"PS Slotwiner","year":"1966","unstructured":"Slotwiner PS, Song SK, Anderson PJ. Sphenomembranous degeneration of muscle induced by vincristine. Archives of Neurology 15: 172\u2013176, 1966","journal-title":"Archives of Neurology"},{"key":"BF03259853_CR35","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1212\/WNL.30.8.867","volume":"30","author":"H Slyter","year":"1980","unstructured":"Slyter H, Liwnicz B, Herrick MK, Mason R. Fatal myeloence-phalopathy caused by intrathecal vincristine. Neurology 30: 867\u2013871, 1980","journal-title":"Neurology"},{"key":"BF03259853_CR36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1182\/blood.V45.3.315.315","volume":"45","author":"MJ Stuart","year":"1975","unstructured":"Stuart MJ, Cuaso C, Miller M, Oski FA. Syndrome of recurrent increased secretion of antidiuretic hormone following multiple doses of vincristine. Blood 45: 315\u2013320, 1975","journal-title":"Blood"},{"key":"BF03259853_CR37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0022-3476(72)80381-0","volume":"81","author":"RM Suskind","year":"1972","unstructured":"Suskind RM, Brusilow SW, Zehr J. Syndrome of inappropriate secretion of antidiuretic hormone produced by vincristine toxicity (with bioassay of ADH level). Journal of Pediatrics 81: 90\u201392, 1972","journal-title":"Journal of Pediatrics"},{"key":"BF03259853_CR38","first-page":"519","volume":"52","author":"W Tobin","year":"1968","unstructured":"Tobin W, Sandier SG. Neurophysiologic alterations induced by vincristine. Cancer Chemotherapy Reports 52: 519\u2013526, 1968","journal-title":"Cancer Chemotherapy Reports"},{"key":"BF03259853_CR39","first-page":"349","volume":"121","author":"QL Uy","year":"1967","unstructured":"Uy QL, Moens TH, Johns RJ, et al. Vincristine neurotoxicity in rodents. Johns Hopkins Medical Journal 121: 349\u2013360, 1967","journal-title":"Johns Hopkins Medical Journal"},{"key":"BF03259853_CR40","first-page":"1369","volume":"286","author":"PL Weiden","year":"1972","unstructured":"Weiden PL, Wright SE. Vincristine neurotoxicity in patients with Charcot-Marie-Tooth syndrome. New England Journal of Medicine 286: 1369\u20131370, 1972","journal-title":"New England Journal of Medicine"},{"key":"BF03259853_CR41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJM197407182910305","volume":"291","author":"HD Weiss","year":"1974","unstructured":"Weiss HD, Walker MD, Wiernik PH. Neurotoxicity of commonly used antineoplastic agents. New England Journal of Medicine 291: 127\u2013157, 1974","journal-title":"New England Journal of Medicine"},{"key":"BF03259853_CR42","first-page":"13","volume":"30","author":"DM Whitelaw","year":"1963","unstructured":"Whitelaw DM, Cowan DH, Cassidy FR, Patterson TA. Clinical experience with vincristine. Cancer Chemotherapy Reports 30: 13\u201320, 1963","journal-title":"Cancer Chemotherapy Reports"},{"key":"BF03259853_CR43","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1136\/bmj.1.6071.1251","volume":"1","author":"JA Whittaker","year":"1977","unstructured":"Whittaker JA, Griffith IP. Recurrent laryngeal nerve paralysis in patients receiving vincristine and vinblastine. British Medical Journal 1: 1251\u20131272, 1977","journal-title":"British Medical Journal"},{"key":"BF03259853_CR44","first-page":"1051","volume-title":"Cold Spring Harbor Conference on Cell Proliferation. III. Cell Motility","author":"L Wilson","year":"1976","unstructured":"Wilson L, Anderson KA, Chin D. Nonstoichiometric poisoning of microtubule polymerization: a model for the mechanism of action of the vinca alkaloids, podophyllotoxin and colchicine. In Goldman et al. (Eds) Cold Spring Harbor Conference on Cell Proliferation. III. Cell Motility, pp. 1051\u20131064, Cold Spring Harbor Laboratory, New York, 1976"},{"key":"BF03259853_CR45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00005072-197004000-00001","volume":"29","author":"H Wisniewski","year":"1970","unstructured":"Wisniewski H, Terry RD, Hirano A. Neurofibrillary pathology. Journal of Neuropathology and Experimental Neurology 29: 163\u2013176, 1970","journal-title":"Journal of Neuropathology and Experimental Neurology"}],"container-title":["Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259853.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03259853\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259853","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T02:54:52Z","timestamp":1600138492000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03259853"}},"subtitle":["Pathophysiology and Management"],"short-title":[],"issued":{"date-parts":[[1986,12]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1986,12]]}},"alternative-id":["BF03259853"],"URL":"https:\/\/doi.org\/10.1007\/bf03259853","relation":{},"ISSN":["0112-5966"],"issn-type":[{"value":"0112-5966","type":"print"}],"subject":[],"published":{"date-parts":[[1986,12]]}}}